Kamuvudine-9
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kamuvudine-9, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Kamuvudine-9 (K9) in Diabetic Macular Edema [Phase 1, Phase 2]